Evidence map›Paper›PMID 30448894›Full record

ArticleMolecular biology reports2019

Antimicrobial activity of bacteriocin-like inhibitory substance produced by Pediococcus pentosaceus: from shake flasks to bioreactor.

Pamela Oliveira de Souza de Azevedo, Attilio Converti, Martin Gierus, Ricardo Pinheiro de Souza Oliveira

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Inhibition ofMicroorganisms · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Influence ofAnimals : an open access journal from MDPI · 2024
    Article
  7. Article
  8. Antimicrobial Activity of Peptides Produced byAnimals : an open access journal from MDPI · 2023
    Article
  9. Antibacterial Effects of Theaflavins againstFoods (Basel, Switzerland) · 2023
    Article
  10. Article
  11. Pan-genomic and comparative analysis ofComputational and structural biotechnology journal · 2022
    Article
  12. Bacteriocins: Properties and potential use as antimicrobials.Journal of clinical laboratory analysis · 2022
    Review
  13. Review
  14. Review
  15. Article
  16. Comparative Genomics ofFrontiers in microbiology · 2020
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Pamela Oliveira de Souza de AzevedoDepartment of Biochemical and Pharmaceutical Technology, University of São Paulo, São Paulo, SP, Brazil.
Attilio ConvertiDepartment of Civil, Chemical and Environmental Engineering, Pole of Chemical Engineering, Via Opera Pia 15, 16145, Genoa, Italy.
Martin GierusDepartment of Agrobiotechnology, Institute of Animal Nutrition, Livestock Products, and Nutrition Physiology (TTE), IFA-Tulln, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria.
Ricardo Pinheiro de Souza OliveiraDepartment of Biochemical and Pharmaceutical Technology, University of São Paulo, São Paulo, SP, Brazil. rpsolive@usp.br.ORCID http://orcid.org/0000-0001-8590-804X
Universidade de São Paulo · BRBOKU University · AT

Funding

CAPES Financial code 001FAPESP 2016/06284-9
6 · The paper itself

Abstract

Bacteriocins are peptides produced by various species of bacteria, especially lactic acid bacteria (LAB), which have a large spectrum of action against spoilage bacteria and foodborne pathogens. However, when not entirely characterized, they are alternatively called bacteriocin-like inhibitory substances (BLIS). Pediococcus pentosaceus ATCC 43200 grew and produced BLIS optimally when cultivated anaerobically in bioreactor for 24 h at 30 °C and 200 rpm in De Man, Rogosa and Sharp (MRS) medium supplemented with 1.5% peptone. Under such optimal conditions, the cell mass concentration (3.41 g/L) was 66% higher, the generation time (1.28 h) 38% shorter and the BLIS activity against different indicator strains significantly higher than in MRS medium without any supplement taken as a control, and the exponential phase started 4 h before. The agar diffusion method showed BLIS inhibition halos against LAB strains with diameter in the range 11.0-19.5 mm and specific areas between 377.1 and 2654.6 mm

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsBacteriocinsBioreactorsFood MicrobiologyListeria monocytogenesPediococcusPediococcus pentosaceusAnti-Bacterial AgentsAnti-Infective AgentsBacteriocinsBacteriocin-like inhibitory substanceFermentation processLactic acid bacteriaNatural antimicrobialProbiotic bacteria

Identifiers

PMID30448894
OpenAlexW2901788978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.